1. 1) Sato S, Hirakata M, Kuwana M, et al. : Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum. 52 : 1571-1576, 2005.
2. 2) Sato S, Hoshino K, Satoh T, et al. : RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis : Association with rapidly progressive interstitial lung disease. Arthritis Rheum. 60 : 2193-2200, 2009.
3. 3) Nakashima R, Imura Y, Kobayashi S, et al. : The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody. Rheumatology (Oxford). 49 : 433-440, 2010.
4. 4) Kato H, Takeuchi O, Sato S, et al. : Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 441 : 101-105, 2006.
5. 5) Nawata Y, Kurasawa K, Takabayashi K, et al. : Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis : prediction and treatment with cyclosporine. J Rheumatol. 26 : 1527-1533, 1999.